MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$60,668K
EPS
-$1.34
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
Research and development
53,684 57,067* 27,094
General and administrative
10,819 17,522* 4,404
Total operating expenses
64,503 74,589 31,498
Loss from operations
-64,503 -74,589* -31,498
Interest income
2,472 871* 1,549
Other income, net
1,363 820* 531
Total other income, net
-1,691* 2,080
Net loss
-60,668 -72,898 -29,418
Basic EPS
-1.34 -4.399 -37.18
Diluted EPS
-1.34 -4.399 -37.18
Basic Average Shares
45,276,763 16,570,355 791,127
Diluted Average Shares
45,276,763 16,570,355 791,127
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$60,668K Interest income$2,472K Other income, net$1,363K Loss from operations-$64,503K Total operatingexpenses$64,503K Research and development$53,684K General andadministrative$10,819K

MapLight Therapeutics, Inc. (MPLT)

MapLight Therapeutics, Inc. (MPLT)